Publicacións en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (20)

2022

  1. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

  2. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study: Symptoms, toxicity and quality of life of lung cancer patients

    Radiotherapy and Oncology, Vol. 176, pp. 127-137

2021

  1. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  2. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  3. Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

    npj Breast Cancer, Vol. 7, Núm. 1

2019

  1. Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study

    Cancer Epidemiology, Vol. 58, pp. 25-32

  2. How clinical imaging can assess cancer biology

    Insights into Imaging, Vol. 10, Núm. 1

  3. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region

    Journal of Thoracic Oncology, Vol. 14, Núm. 8, pp. 1360-1369

  4. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

  5. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

    Radiotherapy and Oncology, Vol. 138, pp. 59-67

2017

  1. Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study

    International Journal of Cancer, Vol. 140, Núm. 9, pp. 1976-1984

  2. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

2016

  1. Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids

    ACS Omega, Vol. 1, Núm. 3, pp. 470-475

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  2. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations

    International Journal of Cancer, Vol. 137, Núm. 8, pp. 1870-1878

2013

  1. Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441

2011

  1. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence

    Cancer Cell, Vol. 19, Núm. 6, pp. 728-739

2010

  1. Specific inhibition of protein kinase Cβ expression by antisense RNA affects the activation of jurkat T lymphoma cells

    Journal of Biological Regulators and Homeostatic Agents, Vol. 24, Núm. 3, pp. 273-285

2003

  1. TGF-β-induced apoptosis in human thyrocytes is mediated by p27 kip1 reduction and is overridden in neoplastic thyrocytes by NF-κB activation

    Oncogene, Vol. 22, Núm. 49, pp. 7819-7830

2002

  1. FDG PET in a patient with pseudofractures from osteomalacia

    Revista Espanola de Medicina Nuclear, Vol. 21, Núm. 1, pp. 34-35